AU6266896A - Transvacular and intracellular delivery of lipidized protein s - Google Patents

Transvacular and intracellular delivery of lipidized protein s

Info

Publication number
AU6266896A
AU6266896A AU62668/96A AU6266896A AU6266896A AU 6266896 A AU6266896 A AU 6266896A AU 62668/96 A AU62668/96 A AU 62668/96A AU 6266896 A AU6266896 A AU 6266896A AU 6266896 A AU6266896 A AU 6266896A
Authority
AU
Australia
Prior art keywords
transvacular
intracellular delivery
lipidized protein
lipidized
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62668/96A
Inventor
Bernard Malfroy-Camine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eukarion Inc
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of AU6266896A publication Critical patent/AU6266896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
AU62668/96A 1995-06-07 1996-06-06 Transvacular and intracellular delivery of lipidized protein s Abandoned AU6266896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48211695A 1995-06-07 1995-06-07
US482116 1995-06-07
PCT/US1996/009788 WO1996040248A1 (en) 1995-06-07 1996-06-06 Transvacular and intracellular delivery of lipidized proteins

Publications (1)

Publication Number Publication Date
AU6266896A true AU6266896A (en) 1996-12-30

Family

ID=23914739

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62668/96A Abandoned AU6266896A (en) 1995-06-07 1996-06-06 Transvacular and intracellular delivery of lipidized protein s

Country Status (2)

Country Link
AU (1) AU6266896A (en)
WO (1) WO1996040248A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344886B (en) 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
US20030082191A1 (en) * 2001-08-29 2003-05-01 Poduslo Joseph F. Treatment for central nervous system disorders
CA2542179A1 (en) * 2003-10-10 2005-04-21 Novo Nordisk A/S Il-21 derivatives
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
CA2666426A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S Il-21 variants
KR20140074919A (en) 2011-09-14 2014-06-18 아베테르노 리미티드 Intracellular cell selection
GB201306589D0 (en) 2013-04-11 2013-05-29 Abeterno Ltd Live cell imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04503957A (en) * 1989-03-07 1992-07-16 ジェネンテク，インコーポレイテッド Covalent conjugates of lipids and oligonucleotides

Also Published As

Publication number Publication date
WO1996040248A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU5424196A (en) Intracellular signaling proteins and methods of use
AU5928696A (en) Intracellular delivery of macromolecules
AU1682699A (en) Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
ZA962116B (en) Protein production and delivery
AU6307698A (en) Useful properties of human lactoferrin and variants thereof
AU6030398A (en) Human proteins
AU1088399A (en) F-box proteins and genes
AU1021997A (en) Cd100 antigen and uses therefor
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU7721796A (en) Skin care preparation and method
EP0607408A4 (en) Transvascular and intracellular delivery of lipidized proteins.
HUP9901343A3 (en) P53 protein variants and therapeutical uses thereof
AU7621496A (en) Microsensor and use of such microsensor
AU3092995A (en) Breast specific genes and proteins
AUPN631495A0 (en) Vaccine and biological vector(I)
AU6266896A (en) Transvacular and intracellular delivery of lipidized protein s
AUPN631395A0 (en) Vaccine and biological vector(II)
AU7015396A (en) Cyclin e variants and use thereof
ZA96240B (en) Novel peptides their preparation and use
AU9017598A (en) Human frezzled-like protein
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU5369396A (en) Rest protein and dna
AU8168898A (en) Interferon stimulating protein and uses thereof
AU4459196A (en) Sustained-release preparation and use
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof